Not necessarily, Gary. The parents are most interested in saving their children. Right now, the only drug to treat mutations of Exon 51 in Europe is GSK/Prosensa's drug. AVI decided two years ago to pull out of Europe. GSK's drug is all the European DMD families have. And notwithstanding the side effects of the drug, it seems to work . As GSK just announced, a 12 year-old child on the drug for over two years has experienced a reversal in disease progression and is now walking 60 percent further than before starting the drug more than two years earlier. That is amazing and provides much hope for the European families with DMD children. I am long Sarepta, and have been for years. But I am not going to ignore the competition.